RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 95 filers reported holding RELMADA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $593,207 | -64.1% | 262,481 | -44.6% | 0.01% | -70.0% |
| Q4 2022 | $1,653,154 | -40.2% | 473,683 | +534.1% | 0.03% | -43.4% |
| Q3 2022 | $2,765,000 | +36.8% | 74,700 | -29.8% | 0.05% | -5.4% |
| Q2 2022 | $2,021,000 | -39.2% | 106,420 | -13.6% | 0.06% | -37.1% |
| Q1 2022 | $3,326,000 | +609.2% | 123,229 | +491.9% | 0.09% | +493.3% |
| Q4 2021 | $469,000 | – | 20,819 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 853,206 | $30,041,000 | 3.26% |
| COMMODORE CAPITAL LP | 161,565 | $5,689,000 | 2.27% |
| TANG CAPITAL MANAGEMENT LLC | 200,000 | $7,042,000 | 1.98% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 451,412 | $15,894,000 | 1.30% |
| Avoro Capital Advisors LLC | 1,525,000 | $53,695,000 | 0.93% |
| RTW INVESTMENTS, LP | 1,530,717 | $53,897,000 | 0.84% |
| Pegasus Asset Management, Inc. | 26,958 | $949,000 | 0.48% |
| COWEN AND COMPANY, LLC | 166,942 | $5,878,000 | 0.40% |
| Ikarian Capital, LLC | 290,207 | $10,218,000 | 0.34% |
| Spotlight Asset Group, Inc. | 24,565 | $865,000 | 0.32% |